PDF下载 ( 1907 KB)
Effect of response at 48 hours of treatment of acute kidney injury on short-term prognosis of hepatitis B virus-associated acute-on-chronic liver failure
-
摘要:
目的探讨HBV相关慢加急性肝衰竭（HBV-ACLF）合并急性肾损伤（AKI）患者AKI治疗48 h应答与否对其28 d和90 d预后的影响。方法回顾性分析2012年12月-2014年12月在解放军总医院第五医学中心住院治疗的130例HBV-ACLF合并AKI患者的临床资料,根据AKI治疗48 h的情况分为应答组和无应答组,比较2组患者28 d和90 d生存率,进而筛选28 d和90 d预后独立影响因素。符合正态分布的计量资料2组间比较采用t检验;不符合正态分布的计量资料2组间比较采用Kolmogorow-Smirnov Z秩和检验。计数资料2组间比较则采用χ2检验。采用Kaplan-Meier生存曲线分析2组患者的生存率,并应用logrank检验进行比较。采用Cox回归风险模型进行预后影响因素的单因素及多因素分析。结果 AKI治疗48 h应答组38例（29. 2%）,无应答组92例（70. 8%）。无应答组28 d和90 d生存率均低于应答组（χ2值分别为16. 91、23. 28,P值均<0. 01）。Cox回归分析显示,AKI治疗48 h应答、年龄、血清肌酐、血清钠、INR、...
Abstract:Objective To investigate whether response to the treatment of acute kidney injury ( AKI) is achieved at 48 hours and its effect on the 28-and 90-day prognosis of patients with hepatitis B virus-associated acute-on-chronic liver failure ( HBV-ACLF) and AKI.Methods A retrospective analysis was performed for the clinical data of 130 patients with HBV-ACLF and AKI who were hospitalized and treated in The Fifth Medical Center of Chinese PLA General Hospital from December 2012 to December 2014. According to the response to AKI treatment at 48 hours, the patients were divided into response group and non-response group, and the two groups were compared in terms of 28-and 90-day survival rates to screen out the independent influencing factors for 28-and 90-day prognosis. The t-test was used for comparison of normally distributed continuous data between two groups, and the Kolmogorov-Smirnov Z test was used for comparison of non-normally distributed continuous data between two groups. The chi-square test was used for comparison of categorical data between two groups. The Kaplan-Meier survival curve was used to analyze survival rate, and the log-rank test was used for comparison. The Cox regression model was used to perform the univariate and multivariate analyses of influencing factors for prognosis. Results There were38 patients ( 29. 2%) in the response group and 92 patients ( 70. 8%) in the non-response group. The non-response group had significantly lower 28-and 90-day survival rates than the response group ( χ2= 16. 91, 23. 28, both P < 0. 01) . The Cox regression analysis showed that response to AKI treatment at 48 hours, age, serum creatinine, serum sodium, international normalized ratio, and hepatic encephalopathy were independent risk factors for 28- ( HR ( 95% CI) = 0. 271 ( 0. 116-0. 631) , 1. 024 ( 1. 001-1. 047) , 1. 002 ( 1. 000-1. 005) , 0. 948 ( 0. 904-0. 993) , 1. 451 ( 1. 139-1. 849, 1. 987 ( 1. 076-3. 670) , all P < 0. 05) and 90-day ( HR ( 95% CI) = 0. 292 ( 0. 151-0. 563) , 1. 024 ( 1. 004-1. 044) , 1. 002 ( 1. 000-1. 004) , 0. 946 ( 0. 909-0. 984) , 1. 473 ( 1. 180-1. 839) , 2. 135 ( 1. 232-3. 700) , all P < 0. 05) mortality in patients with HBV-ACLF and AKI. Conclusion Response to AKI treatment at 48 hours can significantly improve the short-term prognosis of patients with HBV-ACLF and AKI. Early diagnosis and active treatment of AKI should be strengthened in clinical practice to improve patient prognosis.
-
Key words:
- liver failure /
- hepatitis B virus /
- acute kidney injury /
- treatment outcome /
- prognosis
-
[1] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2018) [J]. J Clin Hepatol, 2019, 35 (1) :38-44. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南 (2018年版) [J].临床肝胆病杂志, 2019, 35 (1) :38-44. [2] MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144 (7) :1426-1437, 1437. e1421-1429. [3] YOU S, RONG Y, ZHU B, et al. Changing etiology of liver failure in 3, 916 patients from northern China:A 10-year survey[J]. Hepatol Int, 2013, 7 (2) :714-720. [4] FU SJ, GAO GS, HU AR, et al. Short-term prognostic value of serum procalcitonin and common inflammation markers combined with CTP score in patients with acute-on-chronic liver failure[J]. Chin J Pract Intern Med, 2015, 35 (6) :519-521. (in Chinese) 傅叁君, 高国生, 胡爱荣, 等.血清降钙素原和常用炎症指标联合CTP评分对慢加急性肝衰竭短期预后的预测价值[J].中国实用内科杂志, 2015, 35 (6) :519-521. [5] LI XP, WU ZP, ZHANG LL, et al. Advances in diagnosis and treatment of patients with acute-on-chronic liver failure complicated by acute kidney injury[J]. J Clin Hepatol, 2016, 32 (9) :1688-1693. (in Chinese) 李小鹏, 吴振平, 张伦理, 等.慢加急性肝衰竭并发急性肾损伤的诊治进展[J].临床肝胆病杂志, 2016, 32 (9) :1688-1693. [6] HUANG Z, LIN C, FANG J, et al. Acute kidney injury in hepatitis B-related acute-on-chronic liver failure without preexisting liver cirrhosis[J]. Hepatol Int, 2015, 9 (3) :416-423. [7] Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention andtreatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960. [8] ANGELI P, GINES P, WONG F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis:Revised consensus recommendations of the International Club of Ascites[J]. Gut, 2015, 64 (4) :531-537. [9] BELCHER JM, GARCIA-TSAO G, SANYAL AJ, et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis[J]. Hepatology, 2013, 57 (2) :753-762. [10] JIANG QQ, HAN MF, MA K, et al. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis[J]. World J Gastroenterol, 2018, 24 (21) :2300-2310. [11] CAO D, LI DJ, WANG Y, et al. Clinical significance of CTP combined with ABIC score in predicting the short-term prognosis of patients with hepatitis B virus-related acute-onchronic fiver failure[J]. Chin J Hepatol, 2019, 27 (2) :118-122. (in Chinese) 曹丹, 李大江, 王颖, 等. CTP联合ABIC评分预测乙型肝炎相关性慢加急性肝衰竭患者短期预后的临床意义[J].中华肝脏病杂志, 2019, 27 (2) :118-122. [12] ZHANG T, DENG CL, LI Q, et al. Value of model for endstage liver disease score combined with albumin detection in evaluating prognosis of patients with HBV-related acute-on-chronic liver failure[J]. China J Modern Med, 2019, 29 (6) :96-99. (in Chinese) 张庭, 邓存良, 李芹, 等. MELD评分体系联合ALB检测对HBV-ACLF患者预后评估的价值[J].中国现代医学杂志, 2019, 29 (6) :96-99. [13] LI L, HU H, ZHENG XW, et al. Prediction of short-term survival by four scoring systems based on MELD in patients with acute-on-chronic hepatitis B-induced liver failure[J]. J Prac Hepatol, 2018, 21 (3) :417-420. (in Chinese) 李磊, 胡辉, 郑晓玮, 等.四种基于MELD的评分系统对慢加急性乙型肝炎肝衰竭患者短期生存的预测价值分析[J].实用肝脏病杂志, 2018, 21 (3) :417-420. [14] SHI DM, XIANG XG, WANG XL, et al. Risk factors for incidence and prognosis of acute kidney injury in hospitalized patients with liver diseases[J]. Chin Hepatol, 2017, 22 (3) :200-204. (in Chinese) 史冬梅, 项晓刚, 王晓琳, 等.慢性肝病住院患者急性肾损伤的发病及预后相关因素分析[J].肝脏, 2017, 22 (3) :200-204. [15] SHI X, ZHU P, YAN G, et al. Clinical characteristics and long-term outcome of acute kidney injury in patients with HBVrelated acute-on-chronic liver failure[J]. J Viral Hepat, 2016, 23 (11) :920-929. 期刊类型引用(20)
1. 秦鹏，李树森，刘皓，吴广迎. 胃冠状静脉栓塞术在门脉高压性上消化道出血经颈静脉肝内门腔静脉分流术患者中的临床疗效. 血管与腔内血管外科杂志. 2022(09): 1130-1134 . 
百度学术2. 高绍，王宏亮，聂春晖，张岳林，周坦洋，余子牛，杨月，孙军辉. 对比TIPS联合胃冠状静脉栓塞术与单独TIPS治疗肝硬化门静脉高压伴上消化道出血的中远期疗效：Meta分析. 中国介入影像与治疗学. 2022(11): 673-677 . 百度学术3. 张大维，吴东辉，孙兴安. TIPS对肝硬化并发上消化道出血患者近期肝肾功能和远期疗效的影响. 当代医学. 2021(35): 129-130 . 百度学术4. 林纲毅，马洺远，蔡宗洋. 超声引导下门静脉穿刺导引经颈静脉肝内门体分流术联合曲张静脉栓塞治疗食管胃底静脉曲张破裂出血的临床效果. 中国当代医药. 2020(07): 113-116 . 百度学术5. 王宁，林芳明，吕明. TIPS联合GCVE用于门静脉高压并发上消化道大出血的应用价值. 肝脏. 2020(09): 952-954 . 百度学术6. 韩志强. 肝硬化上消化道出血37例外科临床治疗效果观察. 世界最新医学信息文摘. 2019(05): 95+102 . 百度学术7. 张明礼. PTVE联合PSE治疗肝硬化门脉高压并上消化道出血的观察. 实用中西医结合临床. 2019(05): 24-26 . 百度学术8. 孙允涛. 肝硬化门静脉高压并发上消化道出血的相关危险因素分析. 中国民康医学. 2019(10): 81-83 . 百度学术9. 孙巧玉，赖雪珍，河源媛. 门脉高压合并上消化道出血采用PTVE联合PSE手术的效果分析. 现代消化及介入诊疗. 2019(08): 837-841+846 . 百度学术10. 杨荣焕. TIPS和PTVE介入方法治疗肝硬化门静脉高压引起的上消化道出血的优劣差异. 黑龙江医学. 2019(09): 1012-1013+1016 . 百度学术11. 武和平. 不同介入途径胃冠状静脉栓塞术治疗肝硬化门静脉高压出血的临床疗效观察. 现代消化及介入诊疗. 2018(02): 208-210 . 百度学术12. 李广忠. 分析肝硬化门脉高压症下食管静脉曲张破裂出血的危险因素. 智慧健康. 2018(07): 91-92+126 . 百度学术13. 李贤圣，董勤勇，张乐，夏侨，贺军. 经颈静脉门静脉分流术介入治疗门静脉高压引起上消化道出血的疗效分析. 浙江创伤外科. 2018(02): 272-273 . 百度学术14. 赵晓飞，林栋栋，李宁，臧运金，郭庆良，武聚山. 门静脉高压患者脾切断流术后曲张静脉再出血的危险因素分析. 临床肝胆病杂志. 2018(10): 2182-2185 . 
本站查看15. 吴笋. 经颈静脉肝内门体静脉分流术加胃冠状静脉栓塞术治疗门脉高压症初探. 现代医用影像学. 2018(05): 1522-1523+1528 . 百度学术16. 田广俊，池晓玲，常钢，孟凡喆，曹敏玲，黎英贤，徐浩祥，梁宏才，赵朋涛，吴晓菊，萧焕明. 中药灌肠防治TIPS治疗肝硬化门静脉高压伴上消化道出血术后肝性脑病临床观察. 新中医. 2018(12): 87-91 . 百度学术17. 樊春燕，叶晓丽，戴晓婷，吴宇清. 肝硬化门静脉高压并发上消化道出血的相关性分析研究. 血管与腔内血管外科杂志. 2018(05): 381-385 . 百度学术18. 彭虹. 肝硬化门静脉高压并发上消化道出血的相关危险因素分析. 中国继续医学教育. 2017(31): 58-59 . 百度学术19. 张志勇. 不同手术方案治疗肝硬化门脉高压症的临床对比. 临床医药文献电子杂志. 2017(46): 8924-8925 . 百度学术20. 向平，张川，张亮科，唐瑞强，叶继彬. 1例上消化道出血病人护理体会. 世界最新医学信息文摘. 2016(14): 247 . 百度学术其他类型引用(3)
-
百度学术
下载:
